PAR DRUGS AND CHEMICALS
Back to Balance Sheet
|
PAR DRUGS AND CHEMICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹3.85 Cr | ₹3.54 Cr | ₹3.64 Cr | ₹3.96 Cr | ₹8.19 Cr |
What is the latest Total Non-Current Liabilities ratio of PAR DRUGS AND CHEMICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹3.85 Cr |
| Mar2024 | ₹3.54 Cr |
| Mar2023 | ₹3.64 Cr |
| Mar2022 | ₹3.96 Cr |
| Mar2021 | ₹8.19 Cr |
How is Total Non-Current Liabilities of PAR DRUGS AND CHEMICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.85 Cr | 8.67 | |
| Mar2024 | ₹3.54 Cr | -2.75 | |
| Mar2023 | ₹3.64 Cr | -7.99 | |
| Mar2022 | ₹3.96 Cr | -51.70 | |
| Mar2021 | ₹8.19 Cr | - | |
Compare Total Non-Current Liabilities of peers of PAR DRUGS AND CHEMICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PAR DRUGS AND CHEMICALS | ₹106.2 Cr | 2.9% | -6.9% | -22.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
PAR DRUGS AND CHEMICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PAR DRUGS AND CHEMICALS | 2.9% |
-6.9% |
-22.1% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses